Explore more publications!
Healthy Living South Dakota
Got News to Share?

Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 5, 2025

MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering
November 5, 2025

MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering

Indeterminate GlobeNewswire
Celcuity Inc. Schedules Release of Third Quarter 2025 Financial Results and Webcast/Conference Call
November 5, 2025

Celcuity Inc. Schedules Release of Third Quarter 2025 Financial Results and Webcast/Conference Call

Indeterminate GlobeNewswire
Anika Reports Third Quarter 2025 Financial Results
November 5, 2025

Anika Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program
November 5, 2025

The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program

Indeterminate GlobeNewswire
Skye Bioscience Late-Breaking Oral Abstract at ObesityWeek 2025 to Highlight Improvement in Rebound Weight Gain
November 5, 2025

Skye Bioscience Late-Breaking Oral Abstract at ObesityWeek 2025 to Highlight Improvement in Rebound Weight Gain

Indeterminate GlobeNewswire
Pluristyx Executes Key Commercial Clinical Use Licenses for iPSC Portfolio, Enabling Novel Therapies for Regenerative Medicine and Neurological Disease Therapeutics
November 5, 2025

Pluristyx Executes Key Commercial Clinical Use Licenses for iPSC Portfolio, Enabling Novel Therapies for Regenerative Medicine and Neurological Disease Therapeutics

Indeterminate GlobeNewswire
Secura Bio to Participate in the Jefferies Global Healthcare Conference in London
November 5, 2025

Secura Bio to Participate in the Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire
Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference
November 5, 2025

Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire
Atea Pharmaceuticals to Host Third Quarter 2025 Financial Results and Business Update Conference Call on November 12, 2025
November 5, 2025

Atea Pharmaceuticals to Host Third Quarter 2025 Financial Results and Business Update Conference Call on November 12, 2025

Indeterminate GlobeNewswire
Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025
November 5, 2025

Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025

Indeterminate GlobeNewswire
EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments
November 5, 2025

EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments

Indeterminate GlobeNewswire
Larimar Therapeutics Reports Third Quarter 2025 Financial Results
November 5, 2025

Larimar Therapeutics Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Biomea Fusion Showcases Preclinical Advances for BMF-650 and Icovamenib with Low Dose Semaglutide at ObesityWeek® 2025
November 5, 2025

Biomea Fusion Showcases Preclinical Advances for BMF-650 and Icovamenib with Low Dose Semaglutide at ObesityWeek® 2025

Indeterminate GlobeNewswire
Sionna Therapeutics Reports Third Quarter 2025 Financial Results
November 5, 2025

Sionna Therapeutics Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update
November 5, 2025

Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update

Indeterminate GlobeNewswire
BioCryst to Present at Upcoming Investor Conference
November 5, 2025

BioCryst to Present at Upcoming Investor Conference

Indeterminate GlobeNewswire
Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights
November 5, 2025

Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights

Indeterminate GlobeNewswire
BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters
November 5, 2025

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters

Indeterminate GlobeNewswire
Jaya Biosciences Receives U.S. Patent for Novel Methods of Treating Neurological Diseases, Including Alzheimer’s Disease, Expanding its Global Intellectual Property Portfolio
November 5, 2025

Jaya Biosciences Receives U.S. Patent for Novel Methods of Treating Neurological Diseases, Including Alzheimer’s Disease, Expanding its Global Intellectual Property Portfolio

Indeterminate GlobeNewswire
Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 5, 2025

Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions